Jazz Pharmaceuticals JAZZ Operating margin
Operating margin at other companies
Other financials
Where this comes from
Calculated from Jazz Pharmaceuticals’s reported figures.
Based on trailing twelve months.
The official record: Jazz Pharmaceuticals’s 10-Q, filed November 5, 2025, on SEC EDGAR. View the filing →
Ask your AI about Jazz Pharmaceuticals's operating margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Jazz Pharmaceuticals's operating margin?
- Jazz Pharmaceuticals (JAZZ) reported operating margin of -11.9% in Q3 2025.
- How has Jazz Pharmaceuticals's operating margin changed year-over-year?
- Jazz Pharmaceuticals's operating margin decreased by 173.2% year-over-year, from 16.2% to -11.9%.
- What is the long-term trend for Jazz Pharmaceuticals's operating margin?
- Over 4 years (2020 to 2024), Jazz Pharmaceuticals's operating margin has grown at a 2.4% compound annual growth rate (CAGR), from 16% to 17.6%.
- What does operating margin mean?
- The profit left from core operations for every dollar of sales, before interest and taxes.
- How do you interpret operating margin?
- Expanding operating margin shows operating leverage — revenue growing faster than the cost base. Compression points to rising overhead, pricing pressure, or investment ahead of revenue.
- How does operating margin compare across companies?
- Strong cross-company signal within a sector. Capital-light businesses sustain higher operating margins than capital-intensive ones.